China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)

China Resources Double-Crane Pharmaceutical Co.,Ltd. Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,275	3,457	2,630	2,834	2,410	1,844
Short-Term Investments	-	-	-	-	-	100.06
Trading Asset Securities	-	-	200.49	803.58	851.95	758.14
Cash & Short-Term Investments	2,275	3,457	2,831	3,638	3,262	2,702
Cash Growth	-29.90%	22.12%	-22.18%	11.51%	20.73%	28.31%
Accounts Receivable	2,897	2,349	2,211	1,978	2,086	2,004
Other Receivables	71.35	54.48	468.98	66.14	50.5	50.49
Receivables	2,968	2,403	2,680	2,044	2,137	2,054
Inventory	1,584	1,562	1,900	1,665	1,289	1,146
Prepaid Expenses	-	0.01	-	0.59	-	-
Other Current Assets	315.59	215.79	227.89	174.55	112.22	136.17
Total Current Assets	7,142	7,638	7,639	7,523	6,800	6,039
Property, Plant & Equipment	4,131	3,810	3,571	2,957	2,673	2,622
Long-Term Investments	1,056	356.63	350.29	303.43	370.08	34.27
Goodwill	907.9	906.06	934.96	788.19	796.41	839.83
Other Intangible Assets	1,732	1,691	1,648	1,193	1,094	1,074
Long-Term Deferred Tax Assets	133.62	126.49	127.19	73.77	52.22	50.3
Long-Term Deferred Charges	797.51	813	792.3	723.66	569.38	574.94
Other Long-Term Assets	203.32	88.75	103.27	114.6	60.72	43.08
Total Assets	16,106	15,431	15,165	13,676	12,416	11,277
Accounts Payable	797.05	722.51	750.39	847.4	848.05	690.76
Accrued Expenses	1,750	1,329	1,496	1,283	1,149	1,038
Short-Term Debt	103.38	59.47	36.95	4.75	-	57.3
Current Portion of Long-Term Debt	7.79	200.25	0.27	-	-	7
Current Portion of Leases	15.08	22.49	19.46	17.84	-	-
Current Income Taxes Payable	45.34	65.7	77.78	59.62	58.92	48.19
Current Unearned Revenue	286.51	210.2	194.21	201.35	146.24	221.89
Other Current Liabilities	1,876	552.61	507.17	317.31	467.45	278.69
Total Current Liabilities	4,881	3,162	3,082	2,731	2,670	2,341
Long-Term Debt	100.16	-	200	-	-	-
Long-Term Leases	29.31	29.95	32.93	35.43	-	-
Long-Term Unearned Revenue	169.49	180.63	199.61	153.92	101.02	98
Long-Term Deferred Tax Liabilities	151.61	157.36	176.17	120.35	103.62	104.79
Other Long-Term Liabilities	5.67	1.67	5.06	1.11	14.4	14.4
Total Liabilities	5,484	3,641	3,840	3,199	3,040	2,600
Common Stock	1,040	1,040	1,043	1,043	1,043	1,043
Additional Paid-In Capital	181.99	165.19	275.22	149.39	149.39	149.39
Retained Earnings	8,796	10,011	9,415	8,718	8,102	7,414
Treasury Stock	-87.36	-125.56	-175.68	-	-	-
Comprensive Income & Other	3.81	0.25	-1.43	-5.17	-0.28	-3.86
Total Common Equity	9,934	11,090	10,556	9,905	9,294	8,603
Minority Interest	687.26	699.36	768.46	571.06	82.88	74.05
Shareholders' Equity	10,621	11,790	11,325	10,477	9,377	8,677
Total Liabilities & Equity	16,106	15,431	15,165	13,676	12,416	11,277
Total Debt	255.71	312.16	289.61	58.02	-	64.3
Net Cash (Debt)	2,019	3,145	2,541	3,580	3,262	2,638
Net Cash Growth	-31.58%	23.75%	-29.01%	9.73%	23.67%	44.58%
Net Cash Per Share	1.97	3.07	2.45	3.43	3.13	2.53
Filing Date Shares Outstanding	1,027	1,021	1,040	1,043	1,043	1,043
Total Common Shares Outstanding	1,027	1,021	1,040	1,043	1,043	1,043
Working Capital	2,261	4,476	4,556	4,792	4,130	3,697
Book Value Per Share	9.67	10.86	10.15	9.49	8.91	8.25
Tangible Book Value	7,294	8,493	7,973	7,925	7,403	6,689
Tangible Book Value Per Share	7.10	8.32	7.67	7.60	7.10	6.41
Buildings	3,493	2,730	2,579	2,314	2,171	2,151
Machinery	4,153	3,584	3,306	2,758	2,578	2,462
Construction In Progress	366.18	568.24	439.72	272.81	281.03	244.22

Source: S&P Capital IQ. Standard template. Financial Sources.